Findings support pharmacogenetic testing to enhance treatment response in veterans, suggesting improved care outcomes.
Clinically actionable pharmacogenetic variation was highly prevalent in this Veteran cohort. These findings support the integration of preemptive pharmacogenetic testing into psychiatric care; however, further research is needed to evaluate its impact on treatment response, remission rates, and clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Alexander et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: